Literature DB >> 26608193

Criteria for discharge of patients with Ebola virus diseases in high-income countries.

Nazario Bevilacqua, Emanuele Nicastri, Pierangelo Chinello, Vicenzo Puro, Nicola Petrosillo, Antonino Di Caro, Maria Rosaria Capobianchi, Simone Lanini, Francesco Vairo, Michel Pletschette, Alimuddin Zumla, Giuseppe Ippolito.   

Abstract

Entities:  

Mesh：

Year:  2015        PMID： 26608193     DOI： 10.1016/S2214-109X(15)00205-3

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  4 in total

1.  Blood kinetics of Ebola virus in survivors and nonsurvivors.

Authors:  Simone Lanini; Gina Portella; Francesco Vairo; Gary P Kobinger; Antonio Pesenti; Martin Langer; Soccoh Kabia; Giorgio Brogiato; Jackson Amone; Concetta Castilletti; Rossella Miccio; Alimuddin Zumla; Maria Rosaria Capobianchi; Antonino Di Caro; Gino Strada; Giuseppe Ippolito
Journal:  J Clin Invest       Date:  2015-11-09       Impact factor: 14.808

2.  More Challenges From Ebola: Infection of the Central Nervous System.

Authors:  Gary Wong; Xiangguo Qiu; Yuhai Bi; Pierre Formenty; Armand Sprecher; Michael Jacobs; George F Gao; Gary Kobinger
Journal:  J Infect Dis       Date:  2016-10-15       Impact factor: 5.226

3.  Detection of Viral RNA in Tissues following Plasma Clearance from an Ebola Virus Infected Patient.

Authors:  Mirella Biava; Claudia Caglioti; Licia Bordi; Concetta Castilletti; Francesca Colavita; Serena Quartu; Emanuele Nicastri; Francesco Nicola Lauria; Nicola Petrosillo; Simone Lanini; Thomas Hoenen; Gary Kobinger; Alimuddin Zumla; Antonino Di Caro; Giuseppe Ippolito; Maria Rosaria Capobianchi; Eleonora Lalle
Journal:  PLoS Pathog       Date:  2017-01-05       Impact factor: 6.823

Review 4.  Ebola virus disease.

Authors:  Shevin T Jacob; Ian Crozier; William A Fischer; Angela Hewlett; Colleen S Kraft; Marc-Antoine de La Vega; Moses J Soka; Victoria Wahl; Anthony Griffiths; Laura Bollinger; Jens H Kuhn
Journal:  Nat Rev Dis Primers       Date:  2020-02-20       Impact factor: 52.329
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.